Granulomatous disease: is it a nuisance or an asset during PET/computed tomography evaluation of lung cancers?

ObjectivesTo evaluate combined PET-computed tomography (CT) criteria for differentiating between granulomatous disease (GD) and malignancy (CA) in oncologic PET–CT studies.MethodsSixty-two patients who were referred for fluoro-2-deoxyglucose (FDG) PET–CT evaluation of pulmonary lesion(s) without a h